Atopic Dermatitis Epidemiology Forecast

Atopic Dermatitis Insights and Trends

• Atopic dermatitis, also called eczema, is a multifaceted, chronic relapsing inflammatory skin disease commonly associated with other atopic manifestations such as food allergy, allergic rhinitis, and asthma. It is the most common type of skin inflammation that usually starts in early childhood but can occur at any age and can be recurrent or persistent throughout life.
• According to DelveInsight’s estimates, the total prevalent cases of Atopic Dermatitis in the 7MM were approximately 73,243,000 in 2025.
• Atopic dermatitis is a common condition that usually begins in childhood; however, anyone can get the disease at any age. It has been observed that the prevalence of atopic dermatitis is higher in children than adults across 7MM. 
• The Atopic Dermatitis is found to be more prevalent in females than in males.

Atopic Dermatitis Epidemiology Forecast in the United States

• 2025 Prevalent Cases of Atopic Dermatitis: ~73,243,000
• Atopic Dermatitis Growth Rate (2026–2036): 0.4% CAGR

DelveInsight's ‘Atopic Dermatitis – Epidemiology Forecast – 2036’ report delivers an in-depth understanding of the Atopic Dermatitis, historical and forecasted epidemiology in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Atopic Dermatitis  Understanding and Diagnosis Algorithm

Atopic Dermatitis Overview

Atopic dermatitis, also called eczema, is a chronic condition and the most common type of skin inflammation that usually starts in early childhood but can occur at any age and can be recurrent or persistent throughout life. In ‘dermatitis,’ ‘derm’ means ‘skin,’ and ‘itis’ means ‘inflammation.’ Thus, dermatitis is a skin inflammation characterized by itchiness, redness, and a rash caused by genetics, an overactive immune system, infections, allergies, and irritating substances. Half of the patients with moderate-to-severe eczema also have asthma, hay fever (allergic rhinitis), and food allergies; it is the most common chronic skin disease in children.

Atopic Dermatitis Diagnosis

Atopic dermatitis is diagnosed clinically, as there is no specific laboratory test. Diagnosis is based on characteristic features especially pruritus (essential), chronic or relapsing eczematous lesions, typical distribution patterns (e.g., face/extensor areas in infants, flexural areas in older children and adults), and a personal or family history of atopy along with exclusion of other conditions.

Patients may also present with dry skin, excoriations, papules, and lichenification. Absence of itching should prompt reconsideration of the diagnosis. Atopic Dermatitis must be differentiated from other scaly skin disorders (e.g., seborrheic dermatitis in infants). If treatment fails, alternative diagnoses, including nutritional, metabolic, or immunologic conditions, should be evaluated. Elevated IgE levels are common but are not diagnostic. Skin biopsy and microbiological tests may help rule out other or secondary conditions but are not definitive for Atopic Dermatitis.

Further details are provided in the report.

Atopic Dermatitis Epidemiology

Key Findings from Atopic Dermatitis Epidemiological Analysis and Forecast

• According to DelveInsight’s estimates, the total prevalent cases of Atopic Dermatitis in the 7MM were approximately 73,243,000 in 2025.
• It has been observed that the prevalence of atopic dermatitis is higher in children (<18 years); ~35% as compared to adults in the 7MM.
• In 2025, among severity of atopic dermatitis in the US, mild atopic dermatitis was the most prevalent subtype (~14,739,000 cases), followed by moderate atopic dermatitis.
• The atopic dermatitis is found to be more prevalent in females than in males.

Scope of the Report

• The report covers a segment of an executive summary, a descriptive overview of Atopic Dermatitis, explaining its causes, signs and symptoms, and pathogenesis.
• Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.

Report Insights

• Atopic Dermatitis Patient Population Forecast

Report Key Strengths

• Epidemiology‑based (epi‑based) Bottom‑up Forecasting
• 11-year Forecast
• Patient Burden Trends (by geography)

FAQs

• What are the disease risks, burdens, and unmet needs of Atopic Dermatitis? What will be the growth opportunities across the 7MM concerning the patient population with Atopic Dermatitis?
• What is the historical and forecasted Atopic Dermatitis patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?

Reasons to Buy

• Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand key opinion leaders’ perspectives around the diagnostic challenges to overcome barriers in the future.
• Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.